Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2018 | Mar. 19, 2019 | Jun. 29, 2018 | |
Document Information [Line Items] | |||
Entity Registrant Name | CATASYS, INC. | ||
Entity Central Index Key | 0001136174 | ||
Trading Symbol | cats | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Emerging Growth Company | false | ||
Entity Small Business | true | ||
Entity Common Stock, Shares Outstanding (in shares) | 16,205,146 | ||
Entity Public Float | $ 31,252,254 | ||
Entity Shell Company | false | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2018 | ||
Document Fiscal Year Focus | 2018 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Current assets | ||
Cash, cash equivalents and restricted cash | $ 3,162 | $ 4,779 |
Receivables, net of allowance for doubtful accounts of $0 and $476, respectively | 1,382 | 511 |
Prepaid and Other Current Assets | 942 | 366 |
Total current assets | 5,486 | 5,656 |
Long-term assets | ||
Property and equipment, net of accumulated depreciation of $1,801 and $1,542, respectively | 263 | 612 |
Restricted cash, long term | 408 | |
Deposits and other assets | 166 | 336 |
Total Assets | 6,323 | 6,604 |
Current liabilities | ||
Accounts payable | 497 | 980 |
Accrued compensation and benefits | 1,537 | 1,177 |
Deferred revenue | 4,195 | 2,914 |
Other accrued liabilities | 1,501 | 578 |
Total current liabilities | 7,730 | 5,649 |
Long-term liabilities | ||
Long term debt, net of discount of $478 and $0, respectively | 7,472 | |
Deferred rent and other long-term liabilities | 25 | |
Capital leases | 2 | |
Warrant liabilities | 86 | 30 |
Total Liabilities | 15,288 | 5,706 |
Commitments and contingencies (note 9) | ||
Stockholders' (deficit)/equity | ||
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common stock, $0.0001 par value; 500,000,000 shares authorized; 16,185,146 and 15,889,171 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively | 2 | 2 |
Additional paid in capital | 296,688 | 294,220 |
Accumulated deficit | (305,655) | (293,324) |
Total Stockholders' (deficit)/equity | (8,965) | 898 |
Total Liabilities and Stockholders' (Deficit)/Equity | $ 6,323 | $ 6,604 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Receivables, allowance for doubtful accounts | $ 0 | $ 476 |
Property and equipment, accumulated dereciation | 1,801 | 1,542 |
Long term debt, discount | $ 478 | $ 0 |
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 50,000,000 | 50,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 16,185,146 | 15,889,171 |
Common stock, shares outstanding (in shares) | 16,185,146 | 15,889,171 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Revenues: | ||
Healthcare services revenues | $ 15,177,000 | $ 7,717,000 |
Operating expenses | ||
Cost of healthcare services | 11,119,000 | 6,391,000 |
General and administrative | 17,395,000 | 11,811,000 |
Depreciation and amortization | 288,000 | 246,000 |
Total operating expenses | 28,802,000 | 18,448,000 |
Loss from operations | (13,625,000) | (10,731,000) |
Other income | 40,000 | 132,000 |
Interest expense | (570,000) | (3,409,000) |
Loss on conversion of note | (1,356,000) | |
Loss on issuance of common stock | (145,000) | |
Change in fair value of warrant liability | (56,000) | 1,778,000 |
Change in fair value of derivative liability | 132,000 | |
Loss before provision for income taxes | (14,211,000) | (13,599,000) |
Provision for income taxes | 1,000 | 6,000 |
Net loss | $ (14,212,000) | $ (13,605,000) |
Basic and diluted net loss per share: (in dollars per share) | $ (0.89) | $ (0.99) |
Basic weighted number of shares outstanding (in shares) | 15,955 | 13,751 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balance (in shares) at Dec. 31, 2016 | 9,214,743 | |||
Conversion of debentures (in shares) | 2,982,994 | |||
Common stock issued for outside services (in shares) | 28,985 | |||
Deferred salary paid in common stock (in shares) | 233,734 | |||
Public offering (in shares) | 3,428,750 | |||
1:6 reverse stock split (in shares) | (35) | |||
Common stock issued for outside services | $ 181,000 | $ 181,000 | ||
Balance (in shares) at Dec. 31, 2017 | 15,889,171 | 15,889,171 | ||
Balance at Dec. 31, 2016 | $ 1,000 | 254,390,000 | $ (279,719,000) | $ (25,328,000) |
Conversion of debentures | 16,509,000 | 16,509,000 | ||
Deferred salary paid in common stock | 1,204,000 | 1,204,000 | ||
Public offering | 1,000 | 16,457,000 | 16,458,000 | |
1:6 reverse stock split | 63,000 | 63,000 | ||
Warrant liability write-off | 6,879,000 | 6,879,000 | ||
Transaction Costs | (2,180,000) | (2,180,000) | ||
Warrants issued for services | 252,000 | 252,000 | ||
Share-based compensation expense | 465,000 | 465,000 | ||
Net loss | (13,605,000) | (13,605,000) | ||
Balance at Dec. 31, 2017 | $ 2,000 | 294,220,000 | (293,324,000) | 898,000 |
Common stock issued for outside services (in shares) | 24,000 | |||
Common stock issued for outside services | 112,000 | $ 112,000 | ||
Cashless warrant exercise (in shares) | 241,975 | |||
Cash warrant exercise (in shares) | 30,000 | |||
Balance (in shares) at Dec. 31, 2018 | 16,185,146 | 16,185,146 | ||
Balance at Dec. 31, 2017 | $ 2,000 | 294,220,000 | (291,443,000) | $ 2,779,000 |
Warrants issued for services | 86,000 | 86,000 | ||
Warrants issued in connection with A/R facility | 64,000 | 64,000 | ||
Cash warrant exercise | 150,000 | 150,000 | ||
Share-based compensation expense | 2,056,000 | 2,056,000 | ||
Net loss | (14,212,000) | (14,212,000) | ||
Balance at Dec. 31, 2018 | $ 2,000 | 296,688,000 | (305,655,000) | (8,965,000) |
Adoption of accounting standard at Dec. 31, 2017 | $ 1,881,000 | $ 1,881,000 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Operating activities: | ||
Net loss | $ (14,212,000) | $ (13,605,000) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 288,000 | 246,000 |
Amortization of debt discount and issuance costs included in interest expense | 187,000 | 3,082,000 |
Loss on disposal of fixed asset | 70,000 | |
Issuance of stock and warrants | 86,000 | 252,000 |
Provision for doubtful accounts | 590,000 | |
Deferred rent | (91,000) | (81,000) |
Share-based compensation expense | 2,056,000 | 465,000 |
Common stock issued for services | 112,000 | 181,000 |
Loss on conversion of convertible note | 1,356,000 | |
Loss on issuance of common stock, related party | 145,000 | |
Fair value adjustment on warrant liability | 56,000 | (1,778,000) |
Fair value adjustment on derivative liability | (132,000) | |
Changes in current assets and liabilities: | ||
Receivables | (871,000) | (49,000) |
Prepaids and other current assets | (311,000) | 54,000 |
Deferred revenue | 3,163,000 | 1,389,000 |
Accounts payable and other accrued liabilities | 893,000 | 517,000 |
Net cash used in operating activities | (8,574,000) | (7,368,000) |
Investing activities: | ||
Purchases of property and equipment | (9,000) | (448,000) |
Deposits and other assets | 71,000 | 35,000 |
Net cash provided by (used in) investing activities | 62,000 | (413,000) |
Financing activities: | ||
Proceeds from the issuance of common stock and warrants | 16,458,000 | |
Proceeds from prom issuance of bridge loan, related party | 1,300,000 | |
Payments on convertible debenture | (4,363,000) | |
Proceeds from loan | 7,500,000 | |
Transactions costs | (1,667,000) | |
Capital lease obligations | (30,000) | (19,000) |
Debt issuance costs | (317,000) | |
Proceeds from warrant exercise | 150,000 | |
Net cash provided by financing activities | 7,303,000 | 11,709,000 |
Net (decrease) increase in cash, cash equivalents and restricted cash | (1,209,000) | 3,928,000 |
Cash, cash equivalents and restricted cash at beginning of period | 4,779,000 | 851,000 |
Cash, cash equivalents and restricted cash at end of period | 3,570,000 | 4,779,000 |
Supplemental disclosure of cash paid | ||
Interest | 363,000 | 106,000 |
Income taxes | 40,000 | |
Supplemental disclosure of non-cash activity | ||
Issuance of stock and warrants | 86,000 | 252,000 |
Common stock issued for conversion of debt and accrued interest | 7,163,000 | |
Common stock issued upon settlement of deferred compensation to officer | 1,122,000 | |
Warrants issued in connection with A/R Facility | 64,000 | |
Common Stock Issued for Consulting Services [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Issuance of stock and warrants | 181,000 | |
Supplemental disclosure of non-cash activity | ||
Issuance of stock and warrants | 181,000 | |
Warrants Issued for Services [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Issuance of stock and warrants | 252,000 | |
Supplemental disclosure of non-cash activity | ||
Issuance of stock and warrants | $ 252,000 |
Note 1 - Summary of Significant
Note 1 - Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | Note 1. Description of Business We harness proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human interaction, to deliver improved member health and cost savings to health plans. We identify, engage and treat health plan members with unaddressed behavioral health conditions that worsen medical comorbidities. Our mission is to help improve the health and save the lives of as many people as possible. We apply advanced data analytics and predictive modeling to identify members with untreated behavioral health conditions, whether diagnosed or not, may Trak not Trak We have contracted with leading national and regional health plans to make On Trak Basis of Consolidation, Presentation, and Liquidity At December 31, 2018, $3.2 $2.2 twelve $762,000 twelve Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our On Trak twenty-two 2019. Management’s Plans Historically, we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. The accompanying financial statements do not We have a growing customer base and believe we are able to fully scale our operations to service the contracts and future enrollment providing leverage in these investments that will generate positive cash flow by the end of 2019. All inter-company transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, revenue recognition, the valuation of warrant liabilities, and shared-based compensation. Actual results could differ from those estimates. Revenue Recognition Revenue from contracts with customers is recognized when, or as, we satisfy our performance obligations by transferring the promised goods or services to the customers. A good or service is transferred to a customer when, or as, the customer obtains control of that good or service. A performance obligation may i.e. not third The following table disaggregates our revenue by contract: For the year ended For the year ended (in thousands) Revenue Percentage Revenue Percentage Commercial $ 9,495 63% $ 2,661 34% Government 5,682 37% 5,056 66% $ 15,177 100% $ 7,717 100% Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis, an upfront case rate, or fee for service based on enrolled members. The Company’s performance obligation is satisfied over time as the On Trak December 31, 2018. Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM Cash and Cash Equivalents We consider all highly liquid investments with an original maturity of three may December 31, 2018, $2.5 Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven Share-Based Compensation Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. We recognize forfeitures when they occur. There were 1,985,539 1,674,864 December 31, 2018 2017, The stock compensation expense was calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2018 December 31, 2017 Expected volatility 100.34% - 102.90 % 102.90 % Risk-free interest rate 2.56 - 2.85 % 2.23 - 2.46 % Weighted average expected lives in years 2.4 - 6.08 10 Expected dividend 0 % 0 % The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the year ended December 31, 2018, No. 107 110 As of December 31, 2018, $6.2 2017 3.12 Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. There were no December 31, 2018 2017, There was no December 31, 2018 2017, There were 24,000 December 31, 2018 $86,000, 90,000 2017 $252,000. There were 9,720 June 2018 12 In September 2018, 250,002 174,015 $0.0001 In November 2018, 156,250 67,960 In December 2018, 30,000 $5.00 $150,000 30,000 There were 1,608,996 2,011,528 December 31, 2018 2017, From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no not no December 31, 2018 2017, Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 no Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 5,370,274 3,896,911 December 31, 2018 2017, Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following tables summarize fair value measurements by level at December 31, 2018 2017, Balance at December 31, 2018 (Amounts in thousands) Level I Level II Level III Total Certificates of deposits (1) 479 - - 479 Total assets 479 - - 479 Warrant liabilities - - 86 86 Total liabilities - - 86 86 ( 1 $71,000 $408,000 December 31, 2018 Balance at December 31, 2017 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 71 - - 71 Total assets 71 - - 71 Warrant liabilities - - 30 30 Total liabilities - - 30 30 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2018, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the years ended December 31, 2018 2017: Level III Warrant (Amounts in thousands) Liabilities Balance as of December 31, 2016 $ 5,307 Issuance (exercise) of warrants, net 2,674 Change in fair value (1,778 ) Write off of warrants (6,173 ) Balance as of December 31, 2017 $ 30 Issuance of warrants - Change in fair value 56 Balance as of December 31, 2018 $ 86 Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840 Variable Interest Entities Generally, an entity is defined as a Variable Interest Entity (“VIE”) under current accounting rules if it either lacks sufficient equity to finance its activities without additional subordinated financial support, or it is structured such that the holders of the voting rights do not As discussed under the heading Management Services Agreement not third not Based on the design of the entity and the lack of sufficient equity to finance its activities without additional working capital loans we have determined that TIH and CIH are VIE’s. We are the primary beneficiary required to consolidate the entity as we have power and potentially significant interests in the entity. Management Services Agreement In April 2018, July 2018, not ● general administrative support services; ● information systems; ● recordkeeping; ● billing and collection; ● obtaining and maintaining all federal, state and local licenses, certifications and regulatory permits. All clinical matters relating to the operation of TIH and CIH and the performance of clinical services through the network of providers shall be the sole and exclusive responsibility of the TIH and CIH Board free of any control or direction by Catasys. TIH pays us a monthly fee equal to the aggregate amount of (a) our costs of providing management services (including reasonable overhead allocable to the delivery of our services and including salaries, rent, equipment, and tenant improvements incurred for the benefit of the medical group, provided that any capitalized costs will be amortized over a five 10% 15% CIH pays us a monthly fee equal to the aggregate amount of (a) our costs of providing management services (including reasonable overhead allocable to the delivery of our services and including salaries, rent, equipment, and tenant improvements incurred for the benefit of the entity, provided that any capitalized costs will be amortized over a five Under the MSA’s, the equity owner of the affiliated treatment center has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We also agree to provide working capital loans to allow for TIH and CIH to pay for their obligations. Substantially all of the activities of TIH and CIH either involves us or are conducted for our benefit, as evidenced by the facts that (i) the operations of TIH and CIH is conducted primarily using our licensed protocols and (ii) under the MSA’s, we agree to provide and perform all non-medical management and administrative services for the TIH and CIH. Payment of our management fee is subordinate to payments of the obligations of TIH and CIH, and repayment of the working capital loans is not third not The amounts and classification of assets and liabilities of the VIE included in our consolidated balance sheets at December 31, 2018 (in thousands) December 31, 2018 Cash and cash equivalents $ 45 Accounts Receivable 94 Prepaid and Other Current Assets 29 Total Assets $ 168 Accounts payable $ 7 Accrued liabilities 14 Total Liabilities $ 21 Warrant Liabilities The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2018 December 31, 2017 Expected volatility 102.90 % 102.90 % Risk-free interest rate 2.63 % 1.89 % Weighted average expected lives in years 1.29 2.29 Expected dividend 0 % 0 % For the years ended December 31, 2018 2017, $56,000 $1.8 Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash, restricted cash and accounts receivable. All of our customers are based in the United States at this time and we are not The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no For the year ended December 31, 2018, four 76% 25%, 25%, 13% 13% four 88% 31%, 27%, 16% 14% For the year ended December 31, 2017, four 90% 36%, 23%, 21%, 10% four 96% 35%, 29%, 17%, 15% Recen tly Issued or Newly Adopted Accounting Pronouncements In August 2018, No. 2018 13, Fair Value Measurement (Topic 820 820, December 15, 2019, In June 2018, 2018 07, Improvements to Nonemployee Share-Based Payment Accounting 2018 07” 505 50 718 December 15, 2018, no 606. not 2018 07 In July 2017, 2017 11, Earnings Per Share (Topic 260 ); Distinguishing Liabilities from Equity (Topic 480 ); Derivatives and Hedging (Topic 815 ): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception 2017 11” no no December 15, 2018, not 2017 11 In November 2016, No. 2016 18, Statement of Cash Flows (Topic 230 2016 18” 2016 18, 2016 18 January 1, 2018. December 31, 2018, 2017: (in thousands) 2018 2017 Cash and cash equivalents $ 3,091 $ 4,779 Restricted cash (current and long-term) 479 - Total cash, cash equivalents and restricted cash $ 3,570 $ 4,779 In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 ) 2016 10” 2014 09, 2014 09, December 15, 2017. 2016 10 $1.9 January 1, 2018 ( 5 In June 2016, 2016 13, Financial Instruments - Credit Losses 2016 13” not first 2021. In February 2016, No. 2016 02, Leases 2016 02” 2016 02 December 15, 2018 January 1, 2019 not $200,000 no |
Note 2 - Accounts Receivable
Note 2 - Accounts Receivable | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | Note 2 . Accounts Receivable Accounts receivables consisted of the following as of December 31, 2018 2017: December 31, (in thousands) 2018 2017 Healthcare fees $ 1,382 $ 985 Other - 2 Total receivables $ 1,382 $ 987 Less allowance for doubtful accounts - (476 ) Total receivables, net $ 1,382 $ 511 We use the specific identification method for recording the provision for doubtful accounts, there was no December 31, 2018 $476,000 December 31, 2017. |
Note 3 - Property and Equipment
Note 3 - Property and Equipment | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | Note 3 . Property and Equipment Property and equipment consisted of the following as of December 31, 2018 2017: (in thousands) 2018 2017 Furniture and equipment $ 1,746 $ 1,836 Leasehold improvements 318 318 Total property and equipment 2,064 2,154 Less accumulated depreciation and amortization (1,801 ) (1,542 ) Total property and equipment, net $ 263 $ 612 Depreciation expense was $288,000 $246,000 December 31, 2018 2017, |
Note 4 - Capital Lease Obligati
Note 4 - Capital Lease Obligations | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Capital Leases in Financial Statements of Lessee Disclosure [Text Block] | Note 4 . Capital Lease Obligations We lease certain computer equipment under agreements entered into during 2016 $68,000 $86,000 December 31, 2018 2017, December 31, 2018 2017 $63,000 $59,000, The future minimum lease payments required under the capital leases and the present values of the net minimum lease payments as of December 31, 2018, (in thousands) Amount Year ending December 31, 2019 $ 2 Total minimum lease payments 2 Less amounts representing interest - Capital lease obligations, net of interest 2 Less current maturities of capital lease obligations (2 ) Long-term capital lease obligations $ - |
Note 5 - ASC 606
Note 5 - ASC 606 | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Revenue from Contract with Customer [Text Block] | Note 5. 606 Revenue Recognition In May 2014, No. 2014 09, Revenue from Contracts with Customers (Topic 606 2014 09” 2014 09 605 605” 605. 606 We adopted ASC 606 January 1, 2018 not January 1, 2018 2014 09 Balance at December 31, 2017 Adjustments Due to Adoption of ASC606 Balance at January 1, 2018 Balance Sheet Liabilities Deferred revenue (2,914 ) 1,881 (1,033 ) Equity Retained earnings (293,324 ) 1,881 (291,443 ) In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated income statement and balance sheet for the year ended December 31, 2018 Year Ended December 31, 2018 As Balances Without Adoption of Effect of Change Income Statement Revenues Healthcare services revenues $ 15,177 $ 9,349 $ 5,828 Net loss (14,212 ) (20,040 ) 5,828 |
Note 6 - Income Taxes
Note 6 - Income Taxes | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | Note 6 . Income Taxes As of December 31, 2018, $260 $186 2023, 2018. Due to such uncertainties surrounding the realization of the deferred tax assets, the Company maintains a valuation allowance of $64.1 $62.4 December 31, 2018 2017, December 31, 2018 2017, $1.7 $29.0 The primary components of temporary differences which give rise to our net deferred tax assets are as follows: 2018 2017 (in thousands) Federal, state and foreign net operating losses $ 62,800 $ 53,911 Stock based compensation 873 4,937 Accrued liabilities 218 157 Fixed Assets 72 - Other temporary differences 315 3,426 Prepaid expenses (176 ) - Valuation allowance (64,102 ) (62,431 ) $ - $ - The Company has provided a valuation allowance in full on its net deferred tax assets in accordance with ASC 740 not 740. A reconciliation between the statutory federal income tax rate and the effective income tax rate for the years ended December 31, 2018 2017 Federal statutory rate 21.0 % -34.0 % State taxes, net of federal benefit 0.0 % -5.5 % Non-deductible share-based compensation -29.3 % 0.0 % Deferred Revenue -2.8 % 0.0 % Change in Foreign NOLS due to liquidation -8.3 % 0.0 % ISO / ESPP 0.0 % 0.3 % Other 3.3 % 249.6 % Change in federal and foreign allowance 16.1 % -210.4 % Tax provision 0.0 % 0.0 % Current accounting rules require that companies recognize in the consolidated financial statements the impact of a tax position, if that position is more likely than not 2015 2017. no December 31, 2018, no The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not not no December 31, 2018 2017, no 2014, 2015. Under Section 382 1986, may may 50% three may Since the Company's formation, the Company has raised capital through the issuance of capital stock on several occasions which, may |
Note 7 - Common Stock
Note 7 - Common Stock | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | Note 7 . Common Stock In September 2018, 250,002 174,015 In November 2018, 156,250 67,960 In December 2018, 30,000 $5.00 $150,000 30,000 In April 2017, 3,125,000 $4.80 $4.464 April 28, 2017. $15.0 Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a 45 468,750 May, 303,750 $1.5 In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on April 26, 2017. In April 2017, 2,982,994 $1.4 twelve December 31, 2017. In April 2017, $1.1 233,734 $83,807 In April 2017, 1 6 six one not No All stock options and warrants to purchase common stock outstanding and our common stock reserved for issuance under our equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by six six During 2018 2017, 24,000 28,985 $112,000 $181,000, |
Note 8 - Share-based Compensati
Note 8 - Share-based Compensation | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | Note 8 . Share-based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 August 2018, 2017 1,400,000 “2017 422A 2017 no ten three five December 31, 2018, 3,761,278 215,909 Share-based compensation expense was approximately $2.1 $465,000 December 31, 2018 2017, Stock Options – Employees and Directors There were 1,985,539 1,674,864 2018 2017, 2018 7.70 Stock option activity for employee and director grants is summarized as follows: Weighted Avg. Aggregate Shares (#) Exercise Price Intrinsic Value Balance, December 31, 2016 244,046 $ 38.94 $ - 2017 Granted 1,674,864 7.50 - Cancelled/Expired (33,527 ) 14.54 - Balance, December 31, 2017 1,885,383 $ 11.46 $ - Exercisable at December 31, 2017 306,612 $ 31.49 $ - 2018 Granted 1,985,539 7.70 - Cancelled/Expired (109,644 ) 14.29 - Balance, December 31, 2018 3,761,278 $ 9.44 $ - Exercisable at December 31, 2018 721,766 $ 17.14 $ - The weighted average remaining contractual life and weighted average exercise price of options outstanding as of December 31, 2018 Options Outstanding Options Exercisable Range of Exercise Prices Shares Weighted Average Remaining Life (yrs) Weighted Average Price Shares Weighted Average Price $0.00 to $10.00 3,412,793 8.60 $ 7.52 465,315 $ 8.00 $10.01 to $100.00 347,790 5.59 26.12 255,756 32.00 $100.01 to $1,200.00 695 0.81 1,108.25 695 1,108.25 3,761,278 8.32 $ 9.44 721,766 $ 17.14 Share-based compensation expense relating to stock options granted to employees and directors was $2.1 $465,000 December 31, 2018 2017, As of December 31, 2018, $6.2 3.12 Stock Options and Warrants – Non-employees In addition to stock options granted under the Plan, we have also granted warrants to purchase our common stock to certain non-employees that have been approved by our Board of Directors. Warrants granted to non-employees outstanding as of December 31, 2018 2017, December 31, 2018 Description Shares (#) Weighted Average Exercise Price Warrants issued in connection with equity offering - $ - Warrants issued in connection with debt agreements 9,720 7.72 Warrants issued for services 24,000 4.68 33,720 $ 5.56 December 31, 2017 Description Shares Weighted Average Exercise Price Warrants issued in connection with equity offering 156,250 $ 6.00 Warrants issued in connection with debt agreements 451,918 4.51 Warrants issued for services 90,000 5.00 698,168 $ 4.91 The following is a summary of warrant activity for the year ended December 31, 2018 2017: Weighted avg. Shares exercise price Outstanding, December 31, 2016 1,313,360 $ 4.82 2017 Issued 698,168 4.90 Exercised - - Outstanding, December 31, 2017 2,011,528 $ 28.40 2018 Issued 33,720 5.56 Exercised (436,252 ) (4.70 ) Outstanding, December 31, 2018 1,608,996 $ 4.71 |
Note 9 - Commitments and Contin
Note 9 - Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | Note 9 . Commitments and Contingencies Operating Lease Commitments We incurred rent expense of approximately $ 296,000 December 31, 2018 2017, Our principal executive and administrative offices are located in Los Angeles, California and consist of leased office space totaling approximately 9,120 April 2019. $33,000 September 2018, 7,869 48 April 2019, $48,000 Rent expense is calculated using the straight-line method based on the total minimum lease payments over the initial term of the lease. Landlord tenant improvement allowances and rent expense exceeding actual rent payments are accounted for as deferred rent liability in the balance sheet and amortized on a straight-line basis over the initial term of the respective leases. Future minimum payments, by year and in the aggregate, under non-cancelable operating leases with initial or remaining terms of one December 31, 2018: (in thousands) Year Amount 2019 $ 406 2020 585 2021 605 2022 626 2023 648 $ 2,870 Future minimum payments primarily relates to our new office lease in Santa Monica, California. Legal Proceedings From time to time, we may not December 31, 2018. |
Note 10 - Related Party Disclos
Note 10 - Related Party Disclosure | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | Note 10 . Related Party Disclosure In January 2017, $1.3 254,904 April 2017, $1.3 In January 2017, December 2016 75% 100% 137,883 In March 2017, July 2015 not .2 31,167 April 2017. In April 2017, 181,154 $869,539 In April 2017, July 2015 $4.3 2,385,111 In April 2017, December 2016 8% $2.9 In April 2017, $1.1 233,734 $83,807 In addition, we have accounts payable outstanding with Mr. Peizer for travel and expenses of approximately $378,000 $254,000 December 31, 2018 2017, |
Note 11 - Short-term Debt
Note 11 - Short-term Debt | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Short-term Debt [Text Block] | Note 11. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( "January 2017 254,904 five one hundred 100% January 2017 $5.10 "January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 |
Note 12 - Long-term Debt
Note 12 - Long-term Debt | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Long-term Debt [Text Block] | Note 12 . Long-Term Debt In June 2018 $7.5 $5.0 $2.5 not $5.0 three November 30, 2018. August 2018, $2.5 three $5.0 November 30, 2018. Repayment of the loans is on an interest-only basis through September 1, 2019, $20.0 six June 30, 2019. 9.75% one 2.0%. 0.2% 0.4% $21,000 twelve December 31, 2018, 6.0% March 1, 2022 3% 2% not $339,000 December 31, 2018. Obligations under the Loan Agreement are secured by a first not The Loan Agreement includes customary affirmative and restrictive covenants, excluding any covenants to attain or maintain certain financial metrics, and also includes customary events of default, including for payment failures, breaches of covenants, change of control and material adverse changes. Upon the occurrence of an event of default and following any applicable cure periods, a default interest rate of an additional 5% may 6% may In connection with the Loan Agreement, we were obligated to pay the Lender a $75,000 We recognized approximately $588,000 $111,000 December 31, 2018 Also in June 2018, $2.5 85% 3.0%. 1% two first not December 31, 2018 The A/R Facility includes customary affirmative and restrictive covenants, including covenants to maintain an asset coverage ratio of at least 2.00 1.00 1.25 1.00 two not 30% three three In connection with the A/R Facility, we issued Heritage Bank of Commerce warrants to purchase an aggregate of 9,720 two $262,000 $71,000 twelve December 31, 2018 |
Note 13 - Restricted Cash
Note 13 - Restricted Cash | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Cash and Cash Equivalents Disclosure [Text Block] | Note 13 . Restricted Cash In September 2018 $408,000. $408,000 May 2019 not $71,000 one February 2019 not December 31, 2018, $408,000 $71,000 The following table provides a reconciliation of cash, cash equivalents and restricted cash for the years ended December 31, 2018 2017: (in thousands) 2018 2017 Cash and cash equivalents $ 3,091 $ 4,779 Restricted cash 479 - Total cash, cash equivalents and restricted cash $ 3,570 $ 4,779 |
Note 14 - Subsequent Events
Note 14 - Subsequent Events | 12 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | Note 14 . Subsequent Events In February 2019, $976,000 none March 19, 2019. In February 2019, 2017 552,884 2017 2017 In March 2019, $15.0 $7.5 June 2018 $7.5 three $2.5 three $5.0 $7.0 $8.0 $2.5 $5.0 not July 1, 2019. $2.5 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2018 | |
Accounting Policies [Abstract] | |
Consolidation, Policy [Policy Text Block] | Basis of Consolidation, Presentation, and Liquidity At December 31, 2018, $3.2 $2.2 twelve $762,000 twelve Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our On Trak twenty-two 2019. Management’s Plans Historically, we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. The accompanying financial statements do not We have a growing customer base and believe we are able to fully scale our operations to service the contracts and future enrollment providing leverage in these investments that will generate positive cash flow by the end of 2019. All inter-company transactions have been eliminated in consolidation. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, revenue recognition, the valuation of warrant liabilities, and shared-based compensation. Actual results could differ from those estimates. |
Revenue Recognition, Policy [Policy Text Block] | Revenue Recognition Revenue from contracts with customers is recognized when, or as, we satisfy our performance obligations by transferring the promised goods or services to the customers. A good or service is transferred to a customer when, or as, the customer obtains control of that good or service. A performance obligation may i.e. not third The following table disaggregates our revenue by contract: For the year ended For the year ended (in thousands) Revenue Percentage Revenue Percentage Commercial $ 9,495 63% $ 2,661 34% Government 5,682 37% 5,056 66% $ 15,177 100% $ 7,717 100% Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis, an upfront case rate, or fee for service based on enrolled members. The Company’s performance obligation is satisfied over time as the On Trak December 31, 2018. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents We consider all highly liquid investments with an original maturity of three may December 31, 2018, $2.5 |
Cost of Sales, Policy [Policy Text Block] | Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | Share-Based Compensation Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. We recognize forfeitures when they occur. There were 1,985,539 1,674,864 December 31, 2018 2017, The stock compensation expense was calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2018 December 31, 2017 Expected volatility 100.34% - 102.90 % 102.90 % Risk-free interest rate 2.56 - 2.85 % 2.23 - 2.46 % Weighted average expected lives in years 2.4 - 6.08 10 Expected dividend 0 % 0 % The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the year ended December 31, 2018, No. 107 110 As of December 31, 2018, $6.2 2017 3.12 Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. There were no December 31, 2018 2017, There was no December 31, 2018 2017, There were 24,000 December 31, 2018 $86,000, 90,000 2017 $252,000. There were 9,720 June 2018 12 In September 2018, 250,002 174,015 $0.0001 In November 2018, 156,250 67,960 In December 2018, 30,000 $5.00 $150,000 30,000 There were 1,608,996 2,011,528 December 31, 2018 2017, From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no not no December 31, 2018 2017, |
Income Tax, Policy [Policy Text Block] | Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 no |
Earnings Per Share, Policy [Policy Text Block] | Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 5,370,274 3,896,911 December 31, 2018 2017, |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following tables summarize fair value measurements by level at December 31, 2018 2017, Balance at December 31, 2018 (Amounts in thousands) Level I Level II Level III Total Certificates of deposits (1) 479 - - 479 Total assets 479 - - 479 Warrant liabilities - - 86 86 Total liabilities - - 86 86 ( 1 $71,000 $408,000 December 31, 2018 Balance at December 31, 2017 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 71 - - 71 Total assets 71 - - 71 Warrant liabilities - - 30 30 Total liabilities - - 30 30 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2018, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the years ended December 31, 2018 2017: Level III Warrant (Amounts in thousands) Liabilities Balance as of December 31, 2016 $ 5,307 Issuance (exercise) of warrants, net 2,674 Change in fair value (1,778 ) Write off of warrants (6,173 ) Balance as of December 31, 2017 $ 30 Issuance of warrants - Change in fair value 56 Balance as of December 31, 2018 $ 86 |
Lessee, Leases [Policy Text Block] | Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840 |
Consolidation, Variable Interest Entity, Policy [Policy Text Block] | Variable Interest Entities Generally, an entity is defined as a Variable Interest Entity (“VIE”) under current accounting rules if it either lacks sufficient equity to finance its activities without additional subordinated financial support, or it is structured such that the holders of the voting rights do not As discussed under the heading Management Services Agreement not third not Based on the design of the entity and the lack of sufficient equity to finance its activities without additional working capital loans we have determined that TIH and CIH are VIE’s. We are the primary beneficiary required to consolidate the entity as we have power and potentially significant interests in the entity. Management Services Agreement In April 2018, July 2018, not ● general administrative support services; ● information systems; ● recordkeeping; ● billing and collection; ● obtaining and maintaining all federal, state and local licenses, certifications and regulatory permits. All clinical matters relating to the operation of TIH and CIH and the performance of clinical services through the network of providers shall be the sole and exclusive responsibility of the TIH and CIH Board free of any control or direction by Catasys. TIH pays us a monthly fee equal to the aggregate amount of (a) our costs of providing management services (including reasonable overhead allocable to the delivery of our services and including salaries, rent, equipment, and tenant improvements incurred for the benefit of the medical group, provided that any capitalized costs will be amortized over a five 10% 15% CIH pays us a monthly fee equal to the aggregate amount of (a) our costs of providing management services (including reasonable overhead allocable to the delivery of our services and including salaries, rent, equipment, and tenant improvements incurred for the benefit of the entity, provided that any capitalized costs will be amortized over a five Under the MSA’s, the equity owner of the affiliated treatment center has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We also agree to provide working capital loans to allow for TIH and CIH to pay for their obligations. Substantially all of the activities of TIH and CIH either involves us or are conducted for our benefit, as evidenced by the facts that (i) the operations of TIH and CIH is conducted primarily using our licensed protocols and (ii) under the MSA’s, we agree to provide and perform all non-medical management and administrative services for the TIH and CIH. Payment of our management fee is subordinate to payments of the obligations of TIH and CIH, and repayment of the working capital loans is not third not The amounts and classification of assets and liabilities of the VIE included in our consolidated balance sheets at December 31, 2018 (in thousands) December 31, 2018 Cash and cash equivalents $ 45 Accounts Receivable 94 Prepaid and Other Current Assets 29 Total Assets $ 168 Accounts payable $ 7 Accrued liabilities 14 Total Liabilities $ 21 |
Warrant Liabilities, Policy [Policy Text Block] | Warrant Liabilities The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2018 December 31, 2017 Expected volatility 102.90 % 102.90 % Risk-free interest rate 2.63 % 1.89 % Weighted average expected lives in years 1.29 2.29 Expected dividend 0 % 0 % For the years ended December 31, 2018 2017, $56,000 $1.8 |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash, restricted cash and accounts receivable. All of our customers are based in the United States at this time and we are not The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no For the year ended December 31, 2018, four 76% 25%, 25%, 13% 13% four 88% 31%, 27%, 16% 14% For the year ended December 31, 2017, four 90% 36%, 23%, 21%, 10% four 96% 35%, 29%, 17%, 15% |
New Accounting Pronouncements, Policy [Policy Text Block] | Recen tly Issued or Newly Adopted Accounting Pronouncements In August 2018, No. 2018 13, Fair Value Measurement (Topic 820 820, December 15, 2019, In June 2018, 2018 07, Improvements to Nonemployee Share-Based Payment Accounting 2018 07” 505 50 718 December 15, 2018, no 606. not 2018 07 In July 2017, 2017 11, Earnings Per Share (Topic 260 ); Distinguishing Liabilities from Equity (Topic 480 ); Derivatives and Hedging (Topic 815 ): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception 2017 11” no no December 15, 2018, not 2017 11 In November 2016, No. 2016 18, Statement of Cash Flows (Topic 230 2016 18” 2016 18, 2016 18 January 1, 2018. December 31, 2018, 2017: (in thousands) 2018 2017 Cash and cash equivalents $ 3,091 $ 4,779 Restricted cash (current and long-term) 479 - Total cash, cash equivalents and restricted cash $ 3,570 $ 4,779 In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 ) 2016 10” 2014 09, 2014 09, December 15, 2017. 2016 10 $1.9 January 1, 2018 ( 5 In June 2016, 2016 13, Financial Instruments - Credit Losses 2016 13” not first 2021. In February 2016, No. 2016 02, Leases 2016 02” 2016 02 December 15, 2018 January 1, 2019 not $200,000 no |
Note 1 - Summary of Significa_2
Note 1 - Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Disaggregation of Revenue [Table Text Block] | For the year ended For the year ended (in thousands) Revenue Percentage Revenue Percentage Commercial $ 9,495 63% $ 2,661 34% Government 5,682 37% 5,056 66% $ 15,177 100% $ 7,717 100% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | December 31, 2018 December 31, 2017 Expected volatility 100.34% - 102.90 % 102.90 % Risk-free interest rate 2.56 - 2.85 % 2.23 - 2.46 % Weighted average expected lives in years 2.4 - 6.08 10 Expected dividend 0 % 0 % |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | Balance at December 31, 2018 (Amounts in thousands) Level I Level II Level III Total Certificates of deposits (1) 479 - - 479 Total assets 479 - - 479 Warrant liabilities - - 86 86 Total liabilities - - 86 86 Balance at December 31, 2017 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 71 - - 71 Total assets 71 - - 71 Warrant liabilities - - 30 30 Total liabilities - - 30 30 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] | Level III Warrant (Amounts in thousands) Liabilities Balance as of December 31, 2016 $ 5,307 Issuance (exercise) of warrants, net 2,674 Change in fair value (1,778 ) Write off of warrants (6,173 ) Balance as of December 31, 2017 $ 30 Issuance of warrants - Change in fair value 56 Balance as of December 31, 2018 $ 86 |
Schedule of Variable Interest Entities [Table Text Block] | (in thousands) December 31, 2018 Cash and cash equivalents $ 45 Accounts Receivable 94 Prepaid and Other Current Assets 29 Total Assets $ 168 Accounts payable $ 7 Accrued liabilities 14 Total Liabilities $ 21 |
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] | December 31, 2018 December 31, 2017 Expected volatility 102.90 % 102.90 % Risk-free interest rate 2.63 % 1.89 % Weighted average expected lives in years 1.29 2.29 Expected dividend 0 % 0 % |
Reconciliation of Cash, Cash Equivalents and Restricted Cash [Table Text Block] | (in thousands) 2018 2017 Cash and cash equivalents $ 3,091 $ 4,779 Restricted cash (current and long-term) 479 - Total cash, cash equivalents and restricted cash $ 3,570 $ 4,779 |
Note 2 - Accounts Receivable (T
Note 2 - Accounts Receivable (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | December 31, (in thousands) 2018 2017 Healthcare fees $ 1,382 $ 985 Other - 2 Total receivables $ 1,382 $ 987 Less allowance for doubtful accounts - (476 ) Total receivables, net $ 1,382 $ 511 |
Note 3 - Property and Equipme_2
Note 3 - Property and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | (in thousands) 2018 2017 Furniture and equipment $ 1,746 $ 1,836 Leasehold improvements 318 318 Total property and equipment 2,064 2,154 Less accumulated depreciation and amortization (1,801 ) (1,542 ) Total property and equipment, net $ 263 $ 612 |
Note 4 - Capital Lease Obliga_2
Note 4 - Capital Lease Obligations (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] | (in thousands) Amount Year ending December 31, 2019 $ 2 Total minimum lease payments 2 Less amounts representing interest - Capital lease obligations, net of interest 2 Less current maturities of capital lease obligations (2 ) Long-term capital lease obligations $ - |
Note 5 - ASC 606 (Tables)
Note 5 - ASC 606 (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] | Balance at December 31, 2017 Adjustments Due to Adoption of ASC606 Balance at January 1, 2018 Balance Sheet Liabilities Deferred revenue (2,914 ) 1,881 (1,033 ) Equity Retained earnings (293,324 ) 1,881 (291,443 ) Year Ended December 31, 2018 As Balances Without Adoption of Effect of Change Income Statement Revenues Healthcare services revenues $ 15,177 $ 9,349 $ 5,828 Net loss (14,212 ) (20,040 ) 5,828 |
Note 6 - Income Taxes (Tables)
Note 6 - Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | 2018 2017 (in thousands) Federal, state and foreign net operating losses $ 62,800 $ 53,911 Stock based compensation 873 4,937 Accrued liabilities 218 157 Fixed Assets 72 - Other temporary differences 315 3,426 Prepaid expenses (176 ) - Valuation allowance (64,102 ) (62,431 ) $ - $ - |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | 2018 2017 Federal statutory rate 21.0 % -34.0 % State taxes, net of federal benefit 0.0 % -5.5 % Non-deductible share-based compensation -29.3 % 0.0 % Deferred Revenue -2.8 % 0.0 % Change in Foreign NOLS due to liquidation -8.3 % 0.0 % ISO / ESPP 0.0 % 0.3 % Other 3.3 % 249.6 % Change in federal and foreign allowance 16.1 % -210.4 % Tax provision 0.0 % 0.0 % |
Note 8 - Share-based Compensa_2
Note 8 - Share-based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] | Options Outstanding Options Exercisable Range of Exercise Prices Shares Weighted Average Remaining Life (yrs) Weighted Average Price Shares Weighted Average Price $0.00 to $10.00 3,412,793 8.60 $ 7.52 465,315 $ 8.00 $10.01 to $100.00 347,790 5.59 26.12 255,756 32.00 $100.01 to $1,200.00 695 0.81 1,108.25 695 1,108.25 3,761,278 8.32 $ 9.44 721,766 $ 17.14 |
Schedule of Other Share-based Compensation, Activity [Table Text Block] | December 31, 2018 Description Shares (#) Weighted Average Exercise Price Warrants issued in connection with equity offering - $ - Warrants issued in connection with debt agreements 9,720 7.72 Warrants issued for services 24,000 4.68 33,720 $ 5.56 December 31, 2017 Description Shares Weighted Average Exercise Price Warrants issued in connection with equity offering 156,250 $ 6.00 Warrants issued in connection with debt agreements 451,918 4.51 Warrants issued for services 90,000 5.00 698,168 $ 4.91 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Weighted avg. Shares exercise price Outstanding, December 31, 2016 1,313,360 $ 4.82 2017 Issued 698,168 4.90 Exercised - - Outstanding, December 31, 2017 2,011,528 $ 28.40 2018 Issued 33,720 5.56 Exercised (436,252 ) (4.70 ) Outstanding, December 31, 2018 1,608,996 $ 4.71 |
Employees and Directors [Member] | |
Notes Tables | |
Share-based Compensation, Stock Options, Activity [Table Text Block] | Weighted Avg. Aggregate Shares (#) Exercise Price Intrinsic Value Balance, December 31, 2016 244,046 $ 38.94 $ - 2017 Granted 1,674,864 7.50 - Cancelled/Expired (33,527 ) 14.54 - Balance, December 31, 2017 1,885,383 $ 11.46 $ - Exercisable at December 31, 2017 306,612 $ 31.49 $ - 2018 Granted 1,985,539 7.70 - Cancelled/Expired (109,644 ) 14.29 - Balance, December 31, 2018 3,761,278 $ 9.44 $ - Exercisable at December 31, 2018 721,766 $ 17.14 $ - |
Note 9 - Commitments and Cont_2
Note 9 - Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] | (in thousands) Year Amount 2019 $ 406 2020 585 2021 605 2022 626 2023 648 $ 2,870 |
Note 13 - Restricted Cash (Tabl
Note 13 - Restricted Cash (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Restricted Cash and Cash Equivalents [Table Text Block] | (in thousands) 2018 2017 Cash and cash equivalents $ 3,091 $ 4,779 Restricted cash 479 - Total cash, cash equivalents and restricted cash $ 3,570 $ 4,779 |
Note 1 - Summary of Significa_3
Note 1 - Summary of Significant Accounting Policies (Details Textual) | Jan. 01, 2017USD ($)shares | Dec. 31, 2018USD ($)$ / sharesshares | Nov. 30, 2018shares | Sep. 30, 2018$ / sharesshares | Jun. 30, 2018shares | Dec. 31, 2018USD ($)$ / sharesshares | Dec. 31, 2017USD ($)$ / sharesshares | Jan. 01, 2019USD ($) | Jan. 01, 2018USD ($) | Dec. 31, 2016shares |
Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 3,091,000 | $ 3,091,000 | $ 4,779,000 | |||||||
Working Capital Deficit | $ 2,200,000 | 2,200,000 | ||||||||
Cash Used, Per Month | $ 762,000 | |||||||||
Number of States in which Entity Operates | 22 | 22 | ||||||||
Cash, Uninsured Amount | $ 2,500,000 | $ 2,500,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1,985,539,000,000 | 1,674,864,000,000 | ||||||||
Share-based Compensation, Total | $ 2,056,000 | $ 465,000 | ||||||||
Class of Warrant or Right, Issued During Period | shares | 33,720 | 698,168 | ||||||||
Class or Warrant or Right, Exercised During the Period | shares | 30,000 | 156,250 | 250,002 | 436,252 | ||||||
Stock Issued During Period, Shares, Exercise of Warrants | shares | 30,000 | 67,960 | 174,015 | |||||||
Common Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||
Class of Warrant or Right, Exercised During Period, Weighted Average Exercise Price | $ / shares | $ 5 | $ 4.70 | ||||||||
Proceeds from Warrant Exercises | $ 150,000 | $ 150,000 | ||||||||
Class of Warrant or Right, Outstanding | shares | 1,608,996 | 1,608,996 | 2,011,528 | 1,313,360 | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 5,370,274 | 3,896,911 | ||||||||
Fair Value Adjustment of Warrants | $ 56,000 | $ (1,778,000) | ||||||||
Retained Earnings (Accumulated Deficit), Ending Balance | $ (305,655,000) | $ (305,655,000) | $ (293,324,000) | $ (291,443,000) | ||||||
Accounting Standards Update 2014-09 [Member] | ||||||||||
Retained Earnings (Accumulated Deficit), Ending Balance | $ 1,881,000 | |||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | ||||||||||
Number of Major Customers | 4 | 4 | ||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Four Customers [Member] | ||||||||||
Concentration Risk, Percentage | 76.00% | 90.00% | ||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer One [Member] | ||||||||||
Concentration Risk, Percentage | 25.00% | 36.00% | ||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Two [Member] | ||||||||||
Concentration Risk, Percentage | 25.00% | 23.00% | ||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Three [Member] | ||||||||||
Concentration Risk, Percentage | 13.00% | 21.00% | ||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Four [Member] | ||||||||||
Concentration Risk, Percentage | 13.00% | 10.00% | ||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | ||||||||||
Number of Major Customers | 4 | 4 | ||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member] | ||||||||||
Concentration Risk, Percentage | 88.00% | 96.00% | ||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member] | ||||||||||
Concentration Risk, Percentage | 31.00% | 35.00% | ||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Two [Member] | ||||||||||
Concentration Risk, Percentage | 27.00% | 29.00% | ||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Three [Member] | ||||||||||
Concentration Risk, Percentage | 16.00% | 17.00% | ||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Four [Member] | ||||||||||
Concentration Risk, Percentage | 14.00% | 15.00% | ||||||||
Cash, Cash Equivalents and Restricted Cash [Member] | ||||||||||
Certificates of Deposit, at Carrying Value | 71,000 | $ 71,000 | ||||||||
Noncurrent Restricted Cash [Member[ | ||||||||||
Certificates of Deposit, at Carrying Value | 408,000 | $ 408,000 | ||||||||
Warrants Related to Investor Relations Services [Member] | ||||||||||
Class of Warrant or Right, Issued During Period | shares | 90,000 | 24,000 | ||||||||
Warrants and Rights, Issued | $ 252,000 | $ 86,000 | ||||||||
Warrants Issued in Connection with A/R Facility [Member] | ||||||||||
Class of Warrant or Right, Issued During Period | shares | 9,720 | |||||||||
The 2017 Stock Incentive Plan [Member] | ||||||||||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $ 6,200,000 | $ 6,200,000 | ||||||||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 3 years 43 days | |||||||||
Share-based Compensation, Total | $ 2,100,000 | $ 465,000 | ||||||||
The 2017 Stock Incentive Plan [Member] | Nonemployees [Member] | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 0 | ||||||||
Share-based Compensation, Total | $ 0 | $ 0 | ||||||||
Maximum [Member] | Accounting Standards Update 2016-02 [Member] | Subsequent Event [Member] | ||||||||||
Balance Sheet Gross-up Due to Adoption of New Accounting Policies | $ 200,000 | |||||||||
Furniture and Equipment [Member] | Minimum [Member] | ||||||||||
Property, Plant and Equipment, Useful Life | 2 years | |||||||||
Furniture and Equipment [Member] | Maximum [Member] | ||||||||||
Property, Plant and Equipment, Useful Life | 7 years | |||||||||
Leasehold Improvements [Member] | Minimum [Member] | ||||||||||
Property, Plant and Equipment, Useful Life | 5 years | |||||||||
Leasehold Improvements [Member] | Maximum [Member] | ||||||||||
Property, Plant and Equipment, Useful Life | 7 years |
Note 1 - Summary of Significa_4
Note 1 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Revenues | $ 15,177 | $ 7,717 |
Revenues, percentage | 100.00% | 100.00% |
Commercial [Member] | ||
Revenues | $ 9,495 | $ 2,661 |
Revenues, percentage | 63.00% | 34.00% |
Government Contract [Member] | ||
Revenues | $ 5,682 | $ 5,056 |
Revenues, percentage | 37.00% | 66.00% |
Note 1 - Summary of Significa_5
Note 1 - Summary of Significant Accounting Policies - Employee and Director Stock Option Activity (Details) | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Expected volatility | 102.90% | |
Weighted average expected lives in years (Year) | 10 years | |
Expected dividend | 0.00% | 0.00% |
Minimum [Member] | ||
Expected volatility | 100.34% | |
Risk-free interest rate | 2.56% | 2.23% |
Weighted average expected lives in years (Year) | 2 years 146 days | |
Maximum [Member] | ||
Expected volatility | 102.90% | |
Risk-free interest rate | 2.85% | 2.46% |
Weighted average expected lives in years (Year) | 6 years 29 days |
Note 1 - Summary of Significa_6
Note 1 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 | |
Total assets | $ 479 | $ 71 | |
Warrant liabilities | 86 | 30 | |
Total liabilities | 86 | 30 | |
Certificates of Deposit [Member] | |||
Certificates of deposits | 479 | [1] | 71 |
Fair Value, Inputs, Level 1 [Member] | |||
Total assets | 479 | 71 | |
Warrant liabilities | |||
Total liabilities | |||
Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member] | |||
Certificates of deposits | 479 | [1] | 71 |
Fair Value, Inputs, Level 2 [Member] | |||
Total assets | |||
Warrant liabilities | |||
Total liabilities | |||
Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member] | |||
Certificates of deposits | [1] | ||
Fair Value, Inputs, Level 3 [Member] | |||
Total assets | |||
Warrant liabilities | 86 | 30 | |
Total liabilities | 86 | 30 | |
Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member] | |||
Certificates of deposits | [1] | ||
[1] | $71,000 is included in cash, cash equivalents and restricted cash and $408,000 is included in restricted cash, long term on our balance sheet as of December 31, 2018 |
Note 1 - Summary of Significa_7
Note 1 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - Warrants [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Balance | $ 30 | $ 5,307 |
Issuance (exercise) of warrants, net | 2,674 | |
Change in fair value | 56 | (1,778) |
Write off of warrants | (6,173) | |
Balance | $ 86 | $ 30 |
Note 1 - Summary of Significa_8
Note 1 - Summary of Significant Accounting Policies - Summary of Amounts and Classification of Assets and Liabilities of the VIE in Our Consolidated Balance Sheets (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Cash and cash equivalents | $ 3,091 | $ 4,779 |
Prepaid and Other Current Assets | 942 | 366 |
Total Assets | 6,323 | 6,604 |
Accounts payable | 497 | 980 |
Total Liabilities | 15,288 | $ 5,706 |
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member] | TIH [Member] | ||
Cash and cash equivalents | 45 | |
Accounts Receivable | 94 | |
Prepaid and Other Current Assets | 29 | |
Total Assets | 168 | |
Accounts payable | 7 | |
Accrued liabilities | 14 | |
Total Liabilities | $ 21 |
Note 1 - Summary of Significa_9
Note 1 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details) | Dec. 31, 2018 | Dec. 31, 2017 |
Measurement Input, Price Volatility [Member] | ||
Warrant liability assumptions | 1.029 | 1.029 |
Measurement Input, Risk Free Interest Rate [Member] | ||
Warrant liability assumptions | 0.0263 | 0.0189 |
Measurement Input, Expected Term [Member] | ||
Warrant liability assumptions | 1.29 | 2.29 |
Measurement Input, Expected Dividend Rate [Member] | ||
Warrant liability assumptions | 0 | 0 |
Note 1 - Summary of Signific_10
Note 1 - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Cash and cash equivalents | $ 3,091 | $ 4,779 |
Restricted cash (current and long-term) | 479 | |
Total cash, cash equivalents and restricted cash | $ 3,570 | $ 4,779 |
Note 2 - Accounts Receivable (D
Note 2 - Accounts Receivable (Details Textual) - USD ($) | Dec. 31, 2018 | Dec. 31, 2017 |
Allowance for Doubtful Accounts Receivable, Ending Balance | $ 0 | $ 476,000 |
Note 2 - Accounts Receivable -
Note 2 - Accounts Receivable - Summary of Accounts Receivables (Details) - USD ($) | Dec. 31, 2018 | Dec. 31, 2017 |
Receivables gross | $ 1,382,000 | $ 987,000 |
Less allowance for doubtful accounts | 0 | (476,000) |
Total receivables, net | 1,382,000 | 511,000 |
Healthcare Fees [Member] | ||
Receivables gross | 1,382,000 | 985,000 |
Other Receivable [Member] | ||
Receivables gross | $ 2,000 |
Note 3 - Property and Equipme_3
Note 3 - Property and Equipment (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Depreciation, Total | $ 288,000 | $ 246,000 |
Note 3 - Property and Equipme_4
Note 3 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Furniture and equipment | $ 1,746 | $ 1,836 |
Leasehold improvements | 318 | 318 |
Total property and equipment | 2,064 | 2,154 |
Less accumulated depreciation and amortization | (1,801) | (1,542) |
Total property and equipment, net | $ 263 | $ 612 |
Note 4 - Capital Lease Obliga_3
Note 4 - Capital Lease Obligations (Details Textual) - Furniture and Equipment [Member] - USD ($) | Dec. 31, 2018 | Dec. 31, 2017 |
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Other Property, Plant, and Equipment, Gross | $ 68,000 | $ 86,000 |
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Property, Plant, and Equipment Other, Accumulated Depreciation | $ 63,000 | $ 59,000 |
Note 4 - Capital Lease Obliga_4
Note 4 - Capital Lease Obligations - Future Minimum Lease Payments Required Under the Capital Leases (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
2019 | $ 2 | |
Total minimum lease payments | 2 | |
Less amounts representing interest | ||
Capital lease obligations, net of interest | 2 | |
Less current maturities of capital lease obligations | (2) | |
Long-term capital lease obligations | $ 2 |
Note 5 - ASC 606 - Adoption of
Note 5 - ASC 606 - Adoption of ASC 606 (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Jan. 01, 2018 | |
Deferred revenue | $ (4,195) | $ (2,914) | $ (1,033) |
Accumulated deficit | (305,655) | (293,324) | (291,443) |
Healthcare services revenues | 15,177 | 7,717 | |
Net loss | (14,212) | $ (13,605) | |
Calculated under Revenue Guidance in Effect before Topic 606 [Member] | |||
Healthcare services revenues | 9,349 | ||
Net loss | (20,040) | ||
Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | |||
Healthcare services revenues | 5,828 | ||
Net loss | $ 5,828 | ||
Accounting Standards Update 2014-09 [Member] | |||
Deferred revenue | 1,881 | ||
Accumulated deficit | $ 1,881 |
Note 6 - Income Taxes (Details
Note 6 - Income Taxes (Details Textual) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Deferred Tax Assets, Valuation Allowance, Total | $ 64,102 | $ 62,431 |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 1,700 | 29,000 |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total | 0 | $ 0 |
Domestic Tax Authority [Member] | ||
Operating Loss Carryforwards, Total | 260,000 | |
State and Local Jurisdiction [Member] | ||
Operating Loss Carryforwards, Total | $ 186,000 |
Note 6 - Income Taxes - Primary
Note 6 - Income Taxes - Primary Components of Net Deferred Tax Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Federal, state and foreign net operating losses | $ 62,800 | $ 53,911 |
Stock based compensation | 873 | 4,937 |
Accrued liabilities | 218 | 157 |
Fixed Assets | 72 | |
Other temporary differences | 315 | 3,426 |
Prepaid expenses | (176) | |
Valuation allowance | $ (64,102) | $ (62,431) |
Note 6 - Income Taxes - Reconci
Note 6 - Income Taxes - Reconciliation Between the Statutory Federal Income Tax Rate and the Effective Income Tax Rate (Details) | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Federal statutory rate | 21.00% | (34.00%) |
State taxes, net of federal benefit | 0.00% | 5.50% |
Non-deductible share-based compensation | 29.30% | 0.00% |
Deferred Revenue | 2.80% | 0.00% |
Change in Foreign NOLS due to liquidation | (8.30%) | 0.00% |
ISO / ESPP | 0.00% | 0.30% |
Other | 3.30% | 249.60% |
Change in federal and foreign allowance | 16.10% | 210.40% |
Tax provision | 0.00% | 0.00% |
Note 7 - Common Stock (Details
Note 7 - Common Stock (Details Textual) | Apr. 28, 2017USD ($)$ / sharesshares | Apr. 25, 2017 | Dec. 31, 2018USD ($)$ / sharesshares | Nov. 30, 2018shares | Sep. 30, 2018shares | May 31, 2017USD ($)shares | Apr. 30, 2017USD ($)shares | Dec. 31, 2018USD ($)$ / sharesshares | Dec. 31, 2017USD ($)$ / sharesshares |
Class or Warrant or Right, Exercised During the Period | shares | 30,000 | 156,250 | 250,002 | 436,252 | |||||
Stock Issued During Period, Shares, Exercise of Warrants | shares | 30,000 | 67,960 | 174,015 | ||||||
Class of Warrant or Right, Exercised During Period, Weighted Average Exercise Price | $ / shares | $ 5 | $ 4.70 | |||||||
Proceeds from Warrant Exercises | $ 150,000 | $ 150,000 | |||||||
Proceeds from Issuance of Common Stock | 16,458,000 | ||||||||
Gain (Loss) on Conversion of Debt | (1,356,000) | ||||||||
Gain (Loss) on Issuance of Common Stock | (145,000) | ||||||||
Stock Issued During Period, Value, Issued for Services | $ 112,000 | $ 181,000 | |||||||
Common Stock [Member] | |||||||||
Stock Issued During Period, Shares, Exercise of Warrants | shares | 241,975 | ||||||||
Stock Issued During Period, Shares, New Issues | shares | 3,428,750 | ||||||||
Stock Issued During Period, Shares, Issued for Services | shares | 24,000 | 28,985 | |||||||
Stock Issued During Period, Value, Issued for Services | |||||||||
Reverse Stock Split [Member] | |||||||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 6 | ||||||||
Chairman and Chief Executive Officer [Member] | |||||||||
Deferred Salary Settled by Shares | $ 1,100,000 | ||||||||
Common Stock Issued for Settlement of Deferred Salary Balance | shares | 233,734 | ||||||||
Gain (Loss) on Issuance of Common Stock | $ (83,807) | ||||||||
Several Investors, Including Acuitas and Shamus [Member] | Convertible Debentures [Member] | |||||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 2,982,994 | ||||||||
Gain (Loss) on Conversion of Debt | $ (1,400,000) | ||||||||
Public Offering [Member] | Joseph Gunnar & Co., LLC [Member] | |||||||||
Stock Issued During Period, Shares, New Issues | shares | 3,125,000 | ||||||||
Shares Issued, Price Per Share | $ / shares | $ 4.80 | ||||||||
Shares Issued, Price Per Share, Net | $ / shares | $ 4.464 | ||||||||
Proceeds from Issuance of Common Stock | $ 15,000,000 | ||||||||
Over-Allotment Option [Member] | Joseph Gunnar & Co., LLC [Member] | |||||||||
Stock Issued During Period, Shares, New Issues | shares | 303,750 | ||||||||
Proceeds from Issuance of Common Stock | $ 1,500,000 | ||||||||
Additional Shares Available for Purchase | shares | 468,750 |
Note 8 - Share-based Compensa_3
Note 8 - Share-based Compensation (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended | |
Aug. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | |
Share-based Compensation, Total | $ 2,056,000 | $ 465,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,985,539,000,000 | 1,674,864,000,000 | |
Employees and Directors [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,985,539 | 1,674,864 | |
The 2017 Stock Incentive Plan [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 2,333,334 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 1,400,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 3,761,278 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 215,909 | ||
Share-based Compensation, Total | $ 2,100,000 | $ 465,000 | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $ 6,200,000 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 3 years 43 days | ||
The 2017 Stock Incentive Plan [Member] | Employees and Directors [Member] | |||
Share-based Compensation, Total | $ 2,100,000 | $ 465,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,985,539 | 1,674,864 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 7.70 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $ 6,200,000 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 3 years 43 days | ||
The 2017 Stock Incentive Plan [Member] | Minimum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||
The 2017 Stock Incentive Plan [Member] | Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 5 years | ||
The 2010 Stock Incentive Plan [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 243,853 |
Note 8 - Share-based Compensa_4
Note 8 - Share-based Compensation - Employee and Director Stock Option Activity (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Granted, shares (in shares) | 1,985,539,000,000 | 1,674,864,000,000 |
Options Exercisable Shares (in shares) | 721,766 | |
Options Exercisable Weighted Average Price (in dollars per share) | $ 17.14 | |
Balance, shares (in shares) | 3,761,278 | |
Balance, weighted average exercise price (in dollars per share) | $ 9.44 | |
Employees and Directors [Member] | ||
Balance, shares (in shares) | 1,885,383 | 244,046 |
Balance, weighted average exercise price (in dollars per share) | $ 11.46 | $ 38.94 |
Granted, shares (in shares) | 1,985,539 | 1,674,864 |
Granted, weighted average exercise price (in dollars per share) | $ 7.70 | $ 7.50 |
Cancelled/Expired, shares (in shares) | (109,644) | (33,527) |
Cancelled/Expired, weighted average exercise price (in dollars per share) | $ 14.29 | $ 14.54 |
Options Exercisable Shares (in shares) | 306,612 | |
Options Exercisable Weighted Average Price (in dollars per share) | $ 31.49 | |
Balance, shares (in shares) | 3,761,278 | 1,885,383 |
Balance, weighted average exercise price (in dollars per share) | $ 9.44 | $ 11.46 |
Note 8 - Share-based Compensa_5
Note 8 - Share-based Compensation - Options by Exercise Price Range (Details) | 12 Months Ended |
Dec. 31, 2018$ / sharesshares | |
Options Outstanding Shares (in shares) | shares | 3,761,278 |
Options Outstanding Weighted Average Remaining Life (Year) | 8 years 116 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 9.44 |
Options Exercisable Shares (in shares) | shares | 721,766 |
Options Exercisable Weighted Average Price (in dollars per share) | $ 17.14 |
Range One [Member] | |
Lower Exercise Price Limit (in dollars per share) | 0 |
Upper Exercise Price Limit (in dollars per share) | $ 10 |
Options Outstanding Shares (in shares) | shares | 3,412,793 |
Options Outstanding Weighted Average Remaining Life (Year) | 8 years 219 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 7.52 |
Options Exercisable Shares (in shares) | shares | 465,315 |
Options Exercisable Weighted Average Price (in dollars per share) | $ 8 |
Range Two [Member] | |
Lower Exercise Price Limit (in dollars per share) | 10.01 |
Upper Exercise Price Limit (in dollars per share) | $ 100 |
Options Outstanding Shares (in shares) | shares | 347,790 |
Options Outstanding Weighted Average Remaining Life (Year) | 5 years 215 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 26.12 |
Options Exercisable Shares (in shares) | shares | 255,756 |
Options Exercisable Weighted Average Price (in dollars per share) | $ 32 |
Range Three [Member] | |
Lower Exercise Price Limit (in dollars per share) | 100.01 |
Upper Exercise Price Limit (in dollars per share) | $ 1,200 |
Options Outstanding Shares (in shares) | shares | 695 |
Options Outstanding Weighted Average Remaining Life (Year) | 295 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 1,108.25 |
Options Exercisable Shares (in shares) | shares | 695 |
Options Exercisable Weighted Average Price (in dollars per share) | $ 1,108.25 |
Note 8 - Share-based Compensa_6
Note 8 - Share-based Compensation - Stock Options and Warrants Granted to Non-employees for Services Outstanding (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Warrants Issued (in shares) | 33,720 | 698,168 |
Stock Options and Warrants Nonemployees [Member] | ||
Warrants Issued (in shares) | 33,720 | 698,168 |
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 5.56 | $ 4.91 |
Issued in Connection With Equity Offering [Member] | Stock Options and Warrants Nonemployees [Member] | ||
Warrants Issued (in shares) | 156,250 | |
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 6 | |
Issued in Connection With Debt Agreement [Member] | Stock Options and Warrants Nonemployees [Member] | ||
Warrants Issued (in shares) | 9,720 | 451,918 |
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 7.72 | $ 4.51 |
Warrants Issued for Services [Member] | Stock Options and Warrants Nonemployees [Member] | ||
Warrants Issued (in shares) | 24,000 | 90,000 |
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 4.68 | $ 5 |
Note 8 - Share-based Compensa_7
Note 8 - Share-based Compensation - Summary of Warrant Activity (Details) - $ / shares | 1 Months Ended | 12 Months Ended | |||
Dec. 31, 2018 | Nov. 30, 2018 | Sep. 30, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | |
Warrants outstanding, balance (in shares) | 2,011,528 | 1,313,360 | |||
Warrants outstanding, exercise price, balance (in dollars per share) | $ 28.40 | $ 4.82 | |||
Class of Warrant or Right, Issued During Period | 33,720 | 698,168 | |||
Warrants issued, weighted average exercise price (in dollars per share) | $ 5.56 | $ 4.90 | |||
Warrants exercised (in shares) | (30,000) | (156,250) | (250,002) | (436,252) | |
Warrants exercised, weighted average exercise price (in dollars per share) | $ (5) | $ (4.70) | |||
Warrants outstanding, balance (in shares) | 1,608,996 | 1,608,996 | 2,011,528 | ||
Warrants outstanding, exercise price, balance (in dollars per share) | $ 4.71 | $ 4.71 | $ 28.40 |
Note 9 - Commitments and Cont_3
Note 9 - Commitments and Contingencies (Details Textual) | 1 Months Ended | 12 Months Ended | |
Sep. 30, 2018USD ($)ft² | Dec. 31, 2018USD ($)ft² | Dec. 31, 2017USD ($) | |
Operating Leases, Rent Expense, Net, Total | $ 296,000 | $ 296,000 | |
Principal Executive and Administrative Offices [Member] | |||
Area of Real Estate Property | ft² | 9,120 | ||
Operating Lease Monthly Rent | $ 33,000 | ||
Corporate Offices in Santa Monica, California [Member] | |||
Area of Real Estate Property | ft² | 7,869 | ||
Operating Lease Monthly Rent | $ 48,000 | ||
Lessee, Operating Lease, Term of Contract | 4 years |
Note 9 - Commitments and Cont_4
Note 9 - Commitments and Contingencies - Future Minimum Payments, Under Non-cancelable Operating Leases (Details) $ in Thousands | Dec. 31, 2018USD ($) |
2019 | $ 406 |
2020 | 585 |
2021 | 605 |
2022 | 626 |
2023 | 648 |
$ 2,870 |
Note 10 - Related Party Discl_2
Note 10 - Related Party Disclosure (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended | ||||
Apr. 30, 2017 | Jan. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | |
Repayments of Convertible Debt | $ 4,363,000 | |||||
Proceeds from Issuance of Common Stock | 16,458,000 | |||||
Gain (Loss) on Issuance of Common Stock | (145,000) | |||||
Amended Warrants [Member] | ||||||
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | 0.2 | |||||
Acuitas [Member] | Amended Warrants [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 31,167 | |||||
Acuitas [Member] | July 2015 Convertible Debenture [Member] | ||||||
Debt Conversion, Original Debt, Amount | $ 4,300,000 | |||||
Debt Conversion, Converted Instrument, Shares Issued | 2,385,111 | |||||
Acuitas [Member] | Public Offering [Member] | ||||||
Stock Issued During Period, Shares, New Issues | 181,154 | |||||
Proceeds from Issuance of Common Stock | $ 869,539 | |||||
Acuitas [Member] | Amended Warrants [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 31,167 | |||||
Acuitas [Member] | January 2017 Convertible Debenture [Member] | ||||||
Proceeds from Issuance of Debt | $ 1,300,000 | |||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 254,904 | |||||
Repayments of Convertible Debt | 1,300,000 | |||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||
Chairman and Chief Executive Officer [Member] | ||||||
Deferred Salary Settled by Shares | $ 1,100,000 | |||||
Common Stock Issued for Settlement of Deferred Salary Balance | 233,734 | |||||
Gain (Loss) on Issuance of Common Stock | $ (83,807) | |||||
Chairman and Chief Executive Officer [Member] | Travel and Expenses [Member] | ||||||
Due to Related Parties, Current, Total | $ 378,000 | $ 254,000 | ||||
Chairman and Chief Executive Officer [Member] | Acuitas [Member] | ||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | 75.00% | ||||
Shamus [Member] | Acuitas [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 137,883 | |||||
Investors [Member] | December 2016 Convertible Debenture [Member] | ||||||
Repayments of Convertible Debt | $ 2,900,000 | |||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% |
Note 11 - Short-term Debt (Deta
Note 11 - Short-term Debt (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended | ||||
Apr. 30, 2017 | Jan. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | |
Warrant Liabilities, Noncurrent | $ 86,000 | $ 30,000 | ||||
Class of Warrant or Right, Issued During Period | 33,720 | 698,168 | ||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 4.71 | $ 28.40 | $ 4.82 | |||
Repayments of Convertible Debt | $ 4,363,000 | |||||
Acuitas [Member] | January 2017 Convertible Debenture [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 254,904 | |||||
Proceeds from Issuance of Debt | $ 1,300,000 | |||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||
Class of Warrant or Right, Issued During Period | 254,904 | |||||
Repayments of Convertible Debt | $ 1,300,000 | |||||
Amended Warrants [Member] | ||||||
Warrant Liabilities, Noncurrent | $ 5,300,000 | |||||
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | 0.2 | |||||
Write-off of Warrant Liability | $ 6,200,000 | |||||
Amended Warrants [Member] | Accredited Investor [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 13,258 | |||||
Amended Warrants [Member] | Acuitas [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 31,167 | |||||
Warrants Not Subject to Amendment [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 11,049 | |||||
January 2017 Warrants [Member] | Acuitas [Member] | ||||||
Warrant Term | 5 years | |||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | |||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 5.10 | |||||
December 2016 Warrants [Member] | Acuitas [Member] | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 137,883 | |||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 25.00% |
Note 12 - Long-term Debt (Detai
Note 12 - Long-term Debt (Details Textual) | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2018USD ($)shares | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Aug. 31, 2018USD ($) | |
Interest Expense, Total | $ 570,000 | $ 3,409,000 | ||
Debt Instrument, Unamortized Discount, Total | 478,000 | $ 0 | ||
Heritage Warrants [Member] | ||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 9,720 | |||
Corporate Finance [Member] | A/R Facility [Member] | ||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,500,000 | |||
Line of Credit Facility, Percentage of Accounts Receivable as Borrowings | 85.00% | |||
Line of Credit Facility, Commitment Fee Percentage | 1.00% | |||
Debt Instrument, Term | 2 years | |||
Debt Instrument, Covenant Compliance, Asset Coverage Ratio | 2 | |||
Debt Instrument, Covenant Compliance, Asset Coverage Ratio, Minimum | 1.25 | |||
Debt Issuance Costs, Gross | $ 262,000 | |||
Amortization of Debt Issuance Costs | 71,000 | |||
Prime Rate [Member] | Corporate Finance [Member] | A/R Facility [Member] | ||||
Debt Instrument, Basis Spread on Variable Rate | 3.00% | |||
Loan Agreement [Member] | ||||
Debt Instrument, Face Amount | $ 5,000,000 | |||
Debt Instrument, Face Amount of Potential Additional Loan | 2,500,000 | |||
Debt Instrument, Billings Threshold for Additional Loan | 5,000,000 | |||
Achievement of Billing, Additional Loan, Amount | $ 2,500,000 | |||
Debt Instrument, Billings Threshold for Extension | $ 20,000,000 | |||
Debt Instrument, Interest Rate, Stated Percentage | 9.75% | |||
Debt Instrument, Quarterly Revenue Based Payments, Percentage of Consolidated Revenue Payments when EBITDA is Negative | 0.20% | |||
Debt Instrument, Quarterly Revenue Based Payments, Percentage of Consolidated Revenue Payments when EBITDA is Positive | 0.40% | |||
Interest Expense, Total | $ 21,000 | |||
Debt Instrument, Final Payment, Percent of Each Loan Tranche | 6.00% | |||
Debt Instrument, Prepayment Penalty Fee, During Interest-only Payment Period, Percent | 3.00% | |||
Debt Instrument, Prepayment Penalty Fee, After Interest-only Payment Period, Percent | 2.00% | |||
Interest Expense, Debt, Total | $ 339,000 | |||
Debt Instrument, Interest Rate, Additional Default Amount | 5.00% | |||
Debt Instrument, Late Payment Fee, Percent | 6.00% | |||
Debt Instrument, Fee Amount | $ 75,000 | |||
Debt Instrument, Unamortized Discount, Total | 588,000 | |||
Amortization of Debt Discount (Premium) | $ 111,000 | |||
Loan Agreement [Member] | Maximum [Member] | ||||
Debt Instrument, Face Amount | $ 7,500,000 | |||
Loan Agreement [Member] | Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||
Debt Instrument, Basis Spread on Variable Rate, Threshold Percent | 2.00% |
Note 13 - Restricted Cash (Deta
Note 13 - Restricted Cash (Details Textual) - USD ($) | Dec. 31, 2018 | Sep. 30, 2018 | Dec. 31, 2017 |
Restricted Cash, Total | $ 479,000 | ||
Restricted Cash, Noncurrent | 408,000 | ||
Stand-by Letter of Credit Guarantee [Member] | |||
Restricted Cash, Total | $ 408,000 | ||
Restricted Cash, Noncurrent | 408,000 | ||
Health Plan Contract [Member] | |||
Restricted Cash, Total | $ 71,000 | ||
Restricted Cash, Current | $ 71,000 |
Note 13 - Restricted Cash - Cas
Note 13 - Restricted Cash - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Cash and cash equivalents | $ 3,091 | $ 4,779 |
Restricted cash (current and long-term) | 479 | |
Total cash, cash equivalents and restricted cash | $ 3,570 | $ 4,779 |
Note 14 - Subsequent Events (De
Note 14 - Subsequent Events (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended | ||||
Feb. 28, 2019 | Aug. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | Mar. 19, 2019 | Jun. 30, 2018 | |
Proceeds from Issuance of Long-term Debt, Total | $ 7,500,000 | |||||
Loan Agreement [Member] | ||||||
Debt Instrument, Face Amount | $ 5,000,000 | |||||
Debt Instrument, Face Amount of Potential Additional Loan | 2,500,000 | |||||
Loan Agreement [Member] | Maximum [Member] | ||||||
Debt Instrument, Face Amount | 7,500,000 | |||||
The 2017 Stock Incentive Plan [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 1,400,000 | |||||
Corporate Finance [Member] | A/R Facility [Member] | ||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,500,000 | |||||
Subsequent Event [Member] | Loan Agreement [Member] | ||||||
Debt Instrument, Face Amount of Potential Additional Loan | $ 7,500,000 | |||||
Debt Instrument, Face Amount of Potential Additional Loan, Tranche One | 2,500,000 | |||||
Debt Instrument, First Billings Threshold for Additional Loan | 5,000,000 | |||||
Debt Instrument, Second Billings Threshold for Additional Loan | 7,000,000 | |||||
Debt Instrument, Third Billings Threshold for Additional Loan | 8,000,000 | |||||
Proceeds from Issuance of Long-term Debt, Total | 2,500,000 | |||||
Debt Instrument, Face Amount of Potential Additional Loan, Tranche Two | 2,500,000 | |||||
Debt Instrument, Face Amount of Potential Additional Loan, Tranche Three | 2,500,000 | |||||
Subsequent Event [Member] | Loan Agreement [Member] | Maximum [Member] | ||||||
Debt Instrument, Face Amount | $ 15,000,000 | |||||
Subsequent Event [Member] | The 2017 Stock Incentive Plan [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 552,884 | |||||
Subsequent Event [Member] | Corporate Finance [Member] | A/R Facility [Member] | ||||||
Long-term Line of Credit, Total | $ 0 | |||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,500,000 | |||||
Proceeds from Lines of Credit, Total | $ 976,000 |